SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-082207
Filing Date
2022-07-25
Accepted
2022-07-25 07:00:37
Documents
15
Period of Report
2022-07-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2221718d1_8k.htm   iXBRL 8-K 30593
2 EXHIBIT 10.1 tm2221718d1_ex10-1.htm EX-10.1 11742
6 GRAPHIC tm2221718d1_ex10-1img003.jpg GRAPHIC 15605
7 GRAPHIC tm2221718d1_ex10-1img002.jpg GRAPHIC 1168
  Complete submission text file 0001104659-22-082207.txt   245496

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imrx-20220720.xsd EX-101.SCH 3042
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imrx-20220720_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imrx-20220720_pre.xml EX-101.PRE 22601
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2221718d1_8k_htm.xml XML 3765
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40675 | Film No.: 221100991
SIC: 2834 Pharmaceutical Preparations